分子景观和治疗策略对抗结肠直肠癌
Aakash Patel1,2, Pat Gulhati1,2
1Division of Medical Oncology, Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ 08901, USA.
Cancers
|April 27, 2024
概括
结肠直肠癌 (CRC) 是导致死亡的首要原因,年轻发病例正在增加. 分子洞察力正在推动个性化治疗,改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 结肠直肠癌 (CRC) 仍然是一个重大的全球健康挑战,是全球癌症死亡的第二大原因.
- 虽然CRC的总体发病率下降,但在50岁之前诊断的早期发病例的增加令人担忧.
- 改善患者的治疗结果与先进的分子分析和创新的治疗方法有关.
研究的目的:
- 审查结直肠癌的分子基础,包括涉及瘤发生,转移和治疗耐药性的关键基因.
- 讨论基因组和转录组分析在识别不同CRC亚型及其治疗漏洞方面的作用.
- 为结直肠癌患者提供个性化治疗策略和新兴疗法的概述.
主要方法:
- 关于结肠直肠癌分子生物学现有文献的全面审查.
- 从血液和瘤组织中分析基因组和转录基因组数据.
- 针对性治疗,免疫治疗和临床试验数据的检查.
主要成果:
- 根据分子特征识别不同的CRC亚型.
- 了解驱动CRC进展的关键瘤基因和瘤抑制剂.
- 通过向疗法和免疫疗法改善治疗疗效的证据.
结论:
- 分子表征对于理解CRC异质性和开发有效治疗方法至关重要.
- 个性化治疗策略在改善特定CRC患者子组的治疗结果方面表现有前途.
- 目前正在进行的研究和临床试验正在为结直肠癌管理中的新和不断发展的治疗选择铺平道路.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


